Endometriosis is a common and potentially debilitating gynecologic disorder that is often undiagnosed or misdiagnosed. Enhanced use of clinical diagnostic techniques may reduce the delay in time to diagnosis, and therefore bring more rapid relief to affected patients, limit disease progression, and prevent long-term consequences. Pharmacotherapy based on a woman’s age, symptoms, and preferences plays an important role in the management of endometriosis. In this activity, Frank F. Tu, MD, MPH, describes the burden of endometriosis, diagnosis, and long-term management—including new and emerging treatments that show promise in alleviating pain and other symptoms of the disease.
eNewsletter with interactive benchmarking and audio commentary
After completing this activity, participants should be better able to:
- Identify symptoms of endometriosis and their significant overlap with those of other conditions
- Facilitate an early, accurate diagnosis of endometriosis through the essential steps of a detailed history, a thorough clinical assessment, and a physical examination
- Individualize management strategies based on patient factors and preferences
NPs and PAs
Joint Accreditation Statement
In support of improving patient care, Continuing Education Alliance is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
Nursing contact hours: 1.00, which includes 1.00 hour of pharmacology credit
Nurse planner: Melanie Deal, MSN, FNP-BC, WHNP-BC, University of California, Berkeley, Berkeley, California
AAPA Credit Designation
Continuing Education Alliance has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until February 23, 2021. PAs should claim only credit commensurate with the extent of their participation.
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity is supported by an educational grant from AbbVie Inc.
All faculty and planners participating in continuing education activities (CME) sponsored by Continuing Education Alliance are required to disclose to the audience any relevant support or substantial relationships with providers of commercial products and/or devices discussed in this activity and/or with any commercial supporters of the activity. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Tu: consultant: UroShape; consultant/speakers bureau: AbbVie.
Ms Deal has no relevant financial relationships to disclose.
None of the members of the Planning Committee or CE Alliance staff has any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Read the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 70%.
The estimated time to complete this activity is 1.00 hour.
Release date: March 24, 2020
Expiration date: March 23, 2021
© 2020 Practicing Clinicians Exchange. All Rights Reserved. 97819APCE